Login to Your Account



Thetis using 'salty' chemistry to transform diabetes care

By Marie Powers
News Editor

Wednesday, August 26, 2015
In his 35 years at Pfizer Inc., including tenure as the New York-based pharma's director of R&D operations, Frank Sciavolino was immersed in the science side of the business and didn't necessarily see himself in the role of a CEO.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription